Vera Therapeutics Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Vera Therapeutics Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Vera Therapeutics Inc - Ordinary Shares - Class A
Rating: 1.87916675
Author: Trendlyne DVM scores

about

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protei...

46.52 -0.55 (-1.17%)

151.05% Gain from 52W Low

1.5M

XNAS Volume

XNAS 06 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

3.2 / 100

Technically Bullish

72.0 / 100

No estimates available

Vera Therapeutics Inc (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Vera Therapeutics Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protei...

151.05% Gain from 52W Low

SWOT Analysis

Vera Therapeutics Inc (Class A) Live Price Chart